BOSTON, July 3, 2025 /PRNewswire/ — MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer. The move […]
#Rosal Top Picks
Recent Posts
- NEW YORK, Dec. 11, 2025 /PRNewswire/ — Class
- LAS VEGAS, Dec. 11, 2025 /PRNewswire/ —
- The agency closes its first full year with
- A Bold New Line of Cowgirl Boots Reflecting Reba
- MORRISVILLE, N.C., Dec. 11, 2025 /PRNewswire/
